Why the study?
Although ARNI reduces long-term mortality and hospitalization in heart failure compared to enalapril, its short-term effects on diastolic function remain unclear.
Does sacubitril/valsartan improve left ventricular diastolic parameters in patients with HFrEF?
Cohort (n=60)
No
Does sacubitril/valsartan improve left ventricular diastolic parameters in patients with HFrEF?
Answers are grounded in this paper and cite their sources.
ARNI therapy provides short-term improvement in left ventricular diastolic function in HFrEF patients, detectable by speckle tracking echocardiography.
This study aims to evaluate the torsional dynamics and 2D speckle tracking in heart failure with reduced ejection fraction on patients taking angiotensin receptor neprilysin inhibitors (ARNI) and none. ARNI has been shown to be superior to enalapril in the long term reducing the mortality and hospitalization of heart failure (HF). However short-term effects on diastolic function remain unclear. We sought to evaluate 6 months' effects of ARNI on left ventricular (LV) diastolic parameters determined by speckle tracking and tissue Doppler imaging. This study was carried out in Menoufia University Hospitals including 60 patients of HFrEF during the period from August 2019 to January 2020. (50%) of patients were treated with traditional treatment of heart failure and the remaining were treated with ARNI. Data were collected including history and clinical examination. ECG and speckle tracking and tissue Doppler imaging were done to evaluate the diastolic function. Our results showed no significant difference between the two groups at baseline. There was a significant improvement in the LV diastolic function parameters. Untwisting time and untwisting onset showed the highly significant parameters of improvement. This study concluded that ARNI showed short term improvement of diastolic function of the left ventricle that could be detected by STE.
No takes yet. Share an insight, caveat, or question.
SHAFEY et al. (2020) conducted a cohort in Heart failure with reduced ejection fraction (HFrEF) (n=60). Angiotensin receptor neprilysin inhibitors (ARNI) / Sacubitril/Valsartan vs. Traditional treatment of heart failure was evaluated on Left ventricular (LV) diastolic parameters determined by speckle tracking and tissue Doppler imaging.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: